Average Co-Inventor Count = 4.71
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agouron Pharmaceuticals, Inc. (10 from 174 patents)
2. Pfizer Corporation (7 from 4,455 patents)
3. Concortis Biosystems, Corp. (4 from 4 patents)
4. Pfizer Products Inc. (2 from 47 patents)
5. Other (1 from 832,680 patents)
6. Abbott Laboratories Corporation (1 from 4,177 patents)
7. Novo Nordisk A/s (1 from 1,777 patents)
8. Sorrento Therapeutics, Inc. (1 from 112 patents)
9. Vivasor, Inc. (1 from 10 patents)
10. Concortis Biosystems, Corp., a Wholly Owned Subsidiary of Sorrento Therapeutics, Inc. (1 from 1 patent)
11. Argusina Bioscience Inc. (1 from 1 patent)
25 patents:
1. 12115228 - Drug-conjugates, conjugation methods, and uses thereof
2. 11987622 - Drug-conjugates with a targeting molecule and two different drugs
3. 10967071 - Drug-conjugates, conjugation methods, and uses thereof
4. 10836821 - Drug-conjugates with a targeting molecule and two different drugs
5. 9981046 - Drug-conjugates, conjugation methods, and uses thereof
6. 9884127 - Drug-conjugates, conjugation methods, and uses thereof
7. 9801951 - Drug-conjugates, conjugation methods, and uses thereof
8. 8999981 - [object Object]
9. 8748412 - Phenylalanine derivatives and their use as non-peptide GLP-1 receptor modulators
10. 8530652 - Pyrrolopyrazoles, potent kinase inhibitors
11. 8114871 - 3-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivatives
12. 8067591 - Pyrrolopyrazole, potent kinase inhibitors
13. 7928226 - Salts and polymorphs of a VEGF-R inhibitor
14. 7923457 - Quinoline derivatives
15. 7884117 - Carbonylamino pyrrolopyrazoles, potent kinase inhibitors